The Migraine-Metabolic Connection: Screening for and Addressing Metabolic Syndrome in Patients with Migraine

Abstract

Patients presenting with migraine may benefit from screening for insulin-related comorbidities such as metabolic syndrome. Proper assessment optimizes patient care by simultaneously addressing migraine symptoms and offering therapeutic options that can collectively benefit both conditions and improve not only quality of life but risk factors of cardiovascular disease.